Outset Medical, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Outset Medical, Inc. (OM) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $3.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $1.32M, a 35.00% increase year-over-year.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $2.17M.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $2.73M, a 135.98% increase year-over-year.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$1.83M.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $1.52M.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$5.17M.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$2.62M, a 244.73% decline from fiscal 2022.
- Outset Medical, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.81M, a 69.25% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.49M 10-Q · filed 2026-08-06 | $6.22M derived: sum of 3 quarters · filed 2026-08-06 | $4.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.17M 10-Q · filed 2026-05-07 | $4.90M derived: sum of 2 quarters · filed 2026-05-07 | $3.08M derived: sum of 3 quarters · filed 2026-05-07 | $4.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $909.00K derived: sum of 2 quarters · filed 2026-02-13 | $1.89M derived: sum of 3 quarters · filed 2026-08-06 | $1.52M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$846.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.22M 10-Q · filed 2025-11-10 | -$57.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $980.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $610.00K 10-Q · filed 2026-08-06 | $1.77M derived: sum of 3 quarters · filed 2026-08-06 | -$863.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$370.00K 10-Q · filed 2026-05-07 | $789.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.84M derived: sum of 3 quarters · filed 2026-05-07 | -$4.17M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.47M derived: sum of 2 quarters · filed 2026-02-13 | -$3.80M derived: sum of 3 quarters · filed 2026-02-13 | -$5.17M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.96M derived: sum of 2 quarters · filed 2025-11-10 | -$6.33M 10-Q · filed 2025-11-10 | -$4.84M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.69M 10-Q · filed 2025-08-07 | -$2.21M derived: sum of 3 quarters · filed 2026-02-13 | -$2.60M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$1.37M 10-Q · filed 2025-05-08 | $120.00K derived: sum of 2 quarters · filed 2026-02-13 | -$268.00K derived: sum of 3 quarters · filed 2026-02-13 | -$1.65M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.10M derived: sum of 2 quarters · filed 2026-02-13 | -$284.00K derived: sum of 3 quarters · filed 2026-02-13 | -$2.62M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.77M derived: sum of 2 quarters · filed 2024-11-07 | -$4.11M 10-Q · filed 2024-11-07 | -$4.77M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.72M 10-Q · filed 2024-08-08 | -$4.38M derived: sum of 3 quarters · filed 2025-02-28 | -$10.28M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$2.34M 10-Q · filed 2024-05-09 | -$3.00M derived: sum of 2 quarters · filed 2025-02-28 | -$8.89M derived: sum of 3 quarters · filed 2025-02-28 | -$4.75M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$665.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$6.55M derived: sum of 2 quarters · filed 2025-02-28 | -$2.42M derived: sum of 3 quarters · filed 2025-02-28 | $1.81M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.75M derived: sum of 2 quarters · filed 2023-11-08 | $2.48M 10-Q · filed 2023-11-08 | $4.87M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $4.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $8.37M 10-Q · filed 2023-08-03 | $10.76M derived: sum of 3 quarters · filed 2024-02-21 | $12.75M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $4.23M 10-Q · filed 2023-05-04 | $6.62M derived: sum of 2 quarters · filed 2024-02-21 | $8.61M derived: sum of 3 quarters · filed 2024-02-21 | $9.95M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $4.38M derived: sum of 2 quarters · filed 2024-02-21 | $5.72M derived: sum of 3 quarters · filed 2024-02-21 | $5.89M 10-K · filed 2024-02-21 |
| 2021-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.33M derived: sum of 2 quarters · filed 2022-11-09 | $3.50M 10-Q · filed 2022-11-09 | $3.16M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $1.51M 10-Q · filed 2022-08-02 | $1.17M derived: sum of 3 quarters · filed 2023-02-13 | $3.80M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $164.00K 10-Q · filed 2022-05-05 | -$174.00K derived: sum of 2 quarters · filed 2023-02-13 | $2.45M derived: sum of 3 quarters · filed 2023-02-13 | $4.81M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $2.29M derived: sum of 2 quarters · filed 2023-02-13 | $4.65M derived: sum of 3 quarters · filed 2023-02-13 | $4.80M 10-K · filed 2023-02-13 |
| 2020-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.99M derived: sum of 2 quarters · filed 2021-11-04 | $5.14M 10-Q · filed 2021-11-04 | $4.87M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.51M 10-Q · filed 2021-08-06 | $2.25M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2020-03-31 | $150.00K 10-Q · filed 2021-05-06 | -$113.00K derived: sum of 2 quarters · filed 2022-02-23 | ||
| 2019-12-31 | -$263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $974.00K 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $1.24M 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $457.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |